Cartalax
Bioregulator Tripeptide - Ala-Glu-Asp tripeptide bioregulator studied in connective-tissue research.
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) from the short-peptide bioregulator family, studied in preclinical cartilage, connective-tissue and cellular-aging models. Supplied as a characterized reference standard for in-vitro work.
Cartalax belongs to the short-peptide bioregulator family associated with Khavinson's group, most of whose literature is preclinical and cell-culture based. Because the molecule is only three residues long, identity confirmation and purity on the lot certificate are the main points of characterization.
Cartalax specifications
- Molecular formula
- C12H19N3O8
- Molecular weight
- 333.29 g/mol
- Sequence
- Ala-Glu-Asp
- Residues
- 3 residues (Ala-Glu-Asp)
- Presentation
- Lyophilized powder
- Documented purity
- 99.99% by HPLC
- Available sizes
- 10mg ($65)
- Archived COA lots
- 1
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- Gene-expression regulation - Short regulatory peptides of this class are studied for sequence-specific effects on gene expression in cultured cells.
- Connective-tissue models - Investigated in chondrocyte and fibroblast culture models of cellular aging.
Reported mechanisms in the literature
- Gene-expression regulation - Short regulatory peptides of this class are studied for sequence-specific effects on gene expression in cultured cells. (Khavinson et al.)
- Chondrocyte models - Investigated in chondrocyte and fibroblast culture models of cellular aging. (Preclinical literature)
What Cartalax is researched for
- Gene-expression regulation - Studied for sequence-specific regulatory effects in cultured connective-tissue cells. (Khavinson et al.)
- Chondrocyte models - Investigated in culture models of chondrocyte and fibroblast aging. (Preclinical literature)
Cartalax certificates of analysis on file
Every lot below was tested by an independent laboratory and the full report is published as a PDF. Purity is shown exactly as the report states it. The same records are searchable in the COA library and can be checked on the lot verification page.
| Lot | Tested | Size | Laboratory | HPLC purity | Identity | Certificate |
|---|---|---|---|---|---|---|
| R8S654 | 3 Oct 2026 | 10mg | Freedom Diagnostics | 99.99% | Confirmed (LC-MS/MS) | COA PDF |
Published literature on Cartalax
The mechanisms above trace to peer-reviewed studies indexed on PubMed. These are independent third-party publications, not Aspect Peptides claims. Browse indexed research on PubMed.
Cartalax frequently asked questions
What is Cartalax?
A synthetic tripeptide, Ala-Glu-Asp, from the short-peptide bioregulator family.
Is it approved for human use?
No. It is a research material only, supplied for in-vitro laboratory study.
How is it documented?
Each lot ships with its Certificate of Analysis.
Documented to 99.99% purity by HPLC · third-party COA every lot · from $65 · For laboratory research use only.
Related Longevity & Cellular compounds
- NAD+ - Coenzyme central to cellular energy and repair research.
- Epithalon - Tetrapeptide studied for telomerase and circadian research.
- SS-31 - Cardiolipin-targeting peptide studied for mitochondrial function.
- L-Glutathione - Principal intracellular antioxidant tripeptide for cellular-redox research.
- Thymosin Alpha-1 - Thymic peptide studied for immune modulation.